Labs and Monitoring on GLP-1: What Women Should Ask For

Why monitoring matters more for women

Good GLP-1 care is not a vial in the mail — it is a plan for watching how your body responds. For women, that plan carries extra weight because metabolic and hormonal pictures overlap: insulin resistance, thyroid function, and where you are in the menstrual or menopause transition all shape treatment³. Monitoring is how a clinician catches what needs adjusting and confirms treatment is helping the metabolic problem, not just moving the scale. This guide is a starting point for that conversation, not medical advice, and the exact tests are your clinician's call.

Baseline markers worth discussing

Before or around starting, it is reasonable to ask what baseline your provider will establish. Metabolic markers such as fasting glucose and HbA1c reflect the insulin-resistance picture these medicines act on — the same machinery behind much of PCOS weight⁴. Many programs also look at a lipid panel and, given how often thyroid issues sit alongside metabolic ones in women, thyroid function — TSH specifically is worth a recheck a few months in if you already take levothyroxine, since delayed gastric emptying can plausibly shift how much of your dose you absorb — a case-documented interaction we cover in full in what GLP-1 medication means for thyroid conditions. Ferritin is worth adding to that list rather than waiting for a symptom to force it: it is the marker that most often explains hair shedding on a GLP-1 that the medication alone does not, and it can sit low enough to matter while a standard blood count reads normal. A baseline is what makes later results meaningful; without it, "it's working" is guesswork.

What to track over time

As you titrate, follow-up matters: repeating the metabolic markers shows whether insulin sensitivity is improving, not just whether weight is falling¹. Because GLP-1 treatment changes appetite and intake, a clinician may also keep an eye on how you are eating and tolerating the dose. If you have rheumatoid arthritis or another inflammatory condition, ask whether CRP and ESR are being tracked alongside weight — early evidence links GLP-1 treatment to improvement in both, which we cover in how GLP-1 medication interacts with autoimmune disease in women. A baseline DXA scan is worth the same conversation if you are postmenopausal or losing weight quickly, given what a randomized trial found about bone density on a GLP-1. And for women specifically, the picture includes contraception and pregnancy planning — these medicines are not used in pregnancy — which belongs in every check-in, not only at signup.

Turning labs into a provider question

You do not need to memorize a panel — you need a provider that runs and interprets one. When comparing programs, ask plainly: what do you check at baseline, what do you re-check over time, and who reviews the results? A program that includes real monitoring is doing metabolic care; one that skips it is selling a prescription. That distinction is exactly what our Luna Fit Score methodology rewards. Some sellers split the difference and offer panels as a separate purchase: one we reviewed editorially sells at-home hormone and metabolic panels alongside its prescriptions, at $199 or $169 with an active plan. That is worth pricing against what your own clinician can order and interpret, because a panel you buy yourself still needs somebody to read it in the context of your history. Pair this with our provider-choice checklist, the insulin resistance guide, and the PCOS guide, and bring the questions to a clinician who can see your whole picture. Body composition is the part a panel will not show you, so read what fast loss does to lean mass in midlife alongside it.